ICONIC THERAPEUTICS

iconic-therapeutics-logo

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. It is a biopharmaceutical company that has an exclusive license on issued Yale University patents for a novel recombinant protein called hI-con1. hI-con1 binds tissue factor (TF), triggering natural killer cells to selectively destroy pathologic neovascular blood vessels. Such cells include choroidal neovascularization (CNV) associated with wet age-related macular deg... eneration (wet AMD) and TF-expressing cancer cells and tumor-associated pathologic blood vessels (PBV). In addition to this cell-mediated cytotoxicity, hI-con1 may also interrupt the positive feedback loop between tissue factor and vascular endothelial growth factor (VEGF), thereby reducing VEGF levels. Phase 1 studies with hl-con1 are complete and no dose limited toxicities were observed. Evidence of dose-related biologic activity was observed.

#SimilarOrganizations #People #Financial #Website #More

ICONIC THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2002-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.iconictherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
(650) 437-1000

Email Addresses:
[email protected]

Total Funding:
82.85 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Nginx Euro


Similar Organizations

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.


Current Advisors List

johan-kรถrdel_image

Johan Kรถrdel Member of the Board of Directors @ Iconic Therapeutics
Board_member

bruce-robertson_image

Bruce Robertson Board of Directors @ Iconic Therapeutics
Board_member

todd-foley_image

Todd Foley Board of Directors @ Iconic Therapeutics
Board_member

not_available_image

Jonathan Soderstrom Board of Directors @ Iconic Therapeutics
Board_member

Current Employees Featured

not_available_image

Patrick W. Trown
Patrick W. Trown Chief Scientist @ Iconic Therapeutics
Chief Scientist

george-g-montgomery_image

George G. Montgomery
George G. Montgomery Senior Vice President, Financial Strategy @ Iconic Therapeutics
Senior Vice President, Financial Strategy
2015-04-01

gabriela-burian_image

Gabriela Burian
Gabriela Burian Chief Medical Officer @ Iconic Therapeutics
Chief Medical Officer
2014-08-01

william-greene_image

William Greene
William Greene Chariman and CEO @ Iconic Therapeutics
Chariman and CEO
2014-04-01

Founder


kirk-dornbush_image

Kirk Dornbush

not_available_image

Michael Sherman

Investors List

hbm-partners_image

HBM Partners

HBM Partners investment in Venture Round - Iconic Therapeutics

janssen-labs_image

JLABS

JLABS investment in Venture Round - Iconic Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Venture Round - Iconic Therapeutics

atdc_image

ATDC

ATDC investment in Venture Round - Iconic Therapeutics

mpm-capital_image

MPM Capital

MPM Capital investment in Venture Round - Iconic Therapeutics

lundbeckfond-ventures_image

Lundbeckfonden Ventures

Lundbeckfonden Ventures investment in Venture Round - Iconic Therapeutics

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Venture Round - Iconic Therapeutics

elm-street-ventures_image

Elm Street Ventures

Elm Street Ventures investment in Venture Round - Iconic Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Venture Round - Iconic Therapeutics

diem-bioventures_image

Diem Bioventures

Diem Bioventures investment in Venture Round - Iconic Therapeutics

Official Site Inspections

http://www.iconictherapeutics.com

  • Host name: staticip2.multiscreensite.com
  • IP address: 100.24.208.97
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Iconic Therapeutics"

About - Iconic Therapeutics

Iconic Therapeutics is a biopharmaceutical company built on scientific insight and expertise in Tissue Factor (TF) biology. We are pioneering a new class of TF-targeting molecules that โ€ฆSee details»

Iconic Therapeutics - Crunchbase Company Profile

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. It is a biopharmaceutical company that has an exclusive license on issued Yale University patents for a โ€ฆSee details»

Leadership - Iconic Therapeutics

Iconic Therapeutics leadership information. Dr. Greene has been Iconic Therapeuticsโ€™ CEO and a Director since 2014, bringing 20 years as an operating executive, clinician, investor, and โ€ฆSee details»

Iconic Therapeutics Company Profile | Management and

Www.iconictherapeutics.com Iconic Therapeutics Profile and History Iconic Therapeutics, Inc. is a venture-backed biopharmaceutical company dedicated to translating an understanding of the โ€ฆSee details»

Iconic Therapeutics, Inc. Overview | SignalHire Company Profile

By Q2 2019, Iconic Therapeutics, Inc. has participated in at least 6 funding rounds and has raised a minimum of 135.7M. Funding increased noticeable in Q2 2019 โ€” by 8.9M compared to the โ€ฆSee details»

Iconic Therapeutics - Org Chart, Teams, Culture & Jobs - The Org

View Iconic Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Iconic Therapeutics - PitchBook

Iconic Therapeutics General Information Description. Developer of immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases.See details»

Iconic Therapeutics - VentureRadar

"Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and โ€ฆSee details»

Iconic Therapeutics, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Iconic Therapeutics, Inc. of South San Francisco, CA. Get the latest business insights from Dun & โ€ฆSee details»

Iconic Therapeutics - Portfolio Company Profile, Executives and โ€ฆ

See Iconic Therapeutics's complete profile, including its private equity owner and the number of its executive contacts in our database. Iconic Therapeutics is a clinical stage โ€ฆSee details»

Iconic Therapeutics - Craft

Iconic Therapeutics has 5 employees across 2 locations and $82.5 m in total funding,. See insights on Iconic Therapeutics including office locations, competitors, revenue, financials, โ€ฆSee details»

Iconic Therapeutics - H.I.G. Capital Portfolio Company

Www.iconictherapeutics.com. Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating their understanding of Tissue Factor into a new therapeutic approach โ€ฆSee details»

Investors - Iconic Therapeutics

Iconic Therapeutics Investors InformationSee details»

Iconic Therapeutics - Products, Competitors, Financials, Employees ...

Headquarters Location. 701 Gateway Blvd Suite 100. South San Francisco, California, 94080, United States. 650-437-1000See details»

Iconic Therapeutics - Overview, News & Similar companies

Jan 5, 2022 Iconic Therapeutics contact info: Phone number: (650) 437-1000 Website: www.iconictherapeutics.com What does Iconic Therapeutics do? Iconic Therapeutics, Inc. is a โ€ฆSee details»

Iconic Therapeutics, Inc. (Iconic Therapeutics, Inc.) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ โ€ฆ

Mr. Gover served as founding CEO and as a director of GW Pharmaceuticals plc from the company's inception in 1999 until its sale to Jazz Pharmaceuticals plc for $7.2 billion in 2021. โ€ฆSee details»

contact/location - Iconic Therapeutics

Iconic is translating its understanding of tissue factor (TF) biology into a new class of therapeutics.See details»

Exelixis In-Licenses Iconic Therapeutics' Tissue Factor-Targeting ...

Dec 2, 2020 We are excited to see XB002 make further progress as part of Exelixisโ€™ highly-regarded clinical development organization.โ€ โ€œWe are excited to see this promising molecule โ€ฆSee details»

Inflammation - Iconic Therapeutics

Many acute, intermittent and chronic auto-immune and inflammatory diseases are characterized by a TF-driven up-regulation of critical cytokines and chemokines, which set off a cascade of โ€ฆSee details»

linkstock.net © 2022. All rights reserved